[Synthetic anticoagulation stands the test in internist patients, Thrombosis risk in immobilization cut in half].
D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D065427:Factor Xa Inhibitors; D000077425:Fondaparinux; D006760:Hospitalization; D006801:Humans; D007103:Immobilization / Q000009:adverse effects*; D008875:Middle Aged; D010919:Placebos; D011134:Polysaccharides / Q000627:therapeutic use*; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D010919:Placebos; D011134:Polysaccharides; D000077425:Fondaparinux